The effect of transaxic acid on upper gastrointestinal bleeding

Investigation of transaxic acid effect on treatment of admitted patients due to upper gastrointestinal bleeding

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20130812014333N92

Enrollment

Registered

2018-06-06

Start date

2638-03-23

Completion date

Unknown

Last updated

2018-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Upper Gastrointestinal Bleeding. Acute haemorrhagic gastritis

Interventions

Intervention 1: The first intervention group will receive the usual treatment of upper gastrointestinal bleeding (fluid therapy and pentoprazole infusion). Intervention 2: The second intervention grou

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with diagnosed upper gastrointestinal bleeding

Exclusion criteria

Exclusion criteria: Patients with renal failure and subarachnoid hemorrhage Sensitivity to drug Bleeding of urinary tract

Design outcomes

Primary

Measure	Time frame
The upper gastrointestinal tract amount of bleeding. Timepoint: During the study. Method of measurement: Using information recorded in the patients file.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMehdi Hamzeei

Kermanshah University of Medical Sciences

mehdihz68@gmail.com+98 83 3427 6306

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026